Current treatment status-Undergoing active treatment - Page 25 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment Posts on Medivizor

Hormone therapy: a risk factor for stroke and heart attacks in patients with prostate cancer

Hormone therapy: a risk factor for stroke and heart attacks in patients with prostate cancer

Posted by on Sep 8, 2014 in Prostate cancer | 0 comments

In a nutshell This study examined the link between androgen-deprivation therapy (ADT) and risk for developing heart attack or stroke in patients with prostate cancer. Some background Prostate cancer cells often require androgen hormones (male sex hormones such as testosterone) to grow. ADT is intended to reduce the production of...

Read More

FDA approved drugs in the last 20 years for the treatment of Metastatic Breast Cancer

FDA approved drugs in the last 20 years for the treatment of Metastatic Breast Cancer

Posted by on Aug 31, 2014 in Breast cancer | 0 comments

The article reviews drugs that were approved by the US Food and Drug Administration (FDA) for the treatment of Metastatic Breast Cancer (MBC) in the last 20 years. The authors summarize the clinical studies which lead to FDA approval. ‘First-line therapy’ is the initial treatment used to reduce cancer burden. It is usually the standard...

Read More

What is the optimal treatment for lung cancer that has not responded to chemotherapy?

What is the optimal treatment for lung cancer that has not responded to chemotherapy?

Posted by on Aug 4, 2014 in Lung cancer | 0 comments

In a nutshell This analysis compared the safety and efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors and chemotherapy as second-line treatments for lung cancer that has progressed despite first-line chemotherapy. Some background The first-line (primary) treatment for the majority of lung cancer patients is chemotherapy, but...

Read More

Does the chemotherapy dose schedule matter for early breast cancer treatment?

Does the chemotherapy dose schedule matter for early breast cancer treatment?

Posted by on Jul 28, 2014 in Breast cancer | 0 comments

In a nutshell This study compared the safety and efficacy of three chemotherapy regimens in early breast cancer. Some background Adjuvant chemotherapy, delivered following surgical removal of the tumor, reduces mortality rates in breast cancer. Recent studies have shown that dose-density chemotherapy (which increases the intensity of the therapy...

Read More

Can a cancer vaccine increase prostate-specific antigen doubling time?

Can a cancer vaccine increase prostate-specific antigen doubling time?

Posted by on Jul 14, 2014 in Prostate cancer | 1 comment

In a nutshell This study evaluated the use of prostate-specific antigen doubling time as a marker of effectiveness of the personalized peptide vaccination for castration-resistant prostate cancer. Some background Cancer vaccine is one of the attractive treatment modalities for patients with castration-resistant prostate cancer (progression despite...

Read More

Can lymphocyte to monocyte ratio predict outcome following surgery for stage III colon cancer?

Can lymphocyte to monocyte ratio predict outcome following surgery for stage III colon cancer?

Posted by on Jun 14, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the association between preoperative lymphocyte to monocyte ratio and time to recurrence and overall survival in colon cancer.  Some background Surgery is the principle treatment option for advanced non-metastatic (has not spread to distant organs) colon cancer. 5-fluorouracil-based chemotherapy is the...

Read More

Improving “chemo brain” through cognitive training

Posted by on Apr 24, 2014 in Breast cancer | 5 comments

In a nutshell The current study examined the use of cognitive training in breast cancer survivors experiencing cognitive deficits following chemotherapy. Some background Patients treated with chemotherapy are at a high risk for cognitive deficits, particularly in executive functioning. Executive functions are those that lend control to our...

Read More